OverviewSuggest Edit

Varian Medical Systems is the manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.
TypePublic
Founded1948
HQPalo Alto, CA, US
Websitevarian.com
Employee Ratings4.2
Overall CultureB-

Latest Updates

Employees (est.) (Sept 2019)10,062(+41%)
Job Openings248
Revenue (FY, 2020)$3.2 B(-1%)
Share Price (Apr 2021)$177.1
Cybersecurity ratingBMore

Key People/Management at Varian Medical Systems

Chris Toth

Chris Toth

CEO, Varian, a Siemens Healthineers Company
Kathy Conner

Kathy Conner

Vice President, Marketing & Communications
Livia Freudl

Livia Freudl

Senior Vice President, Head of Human Resources
Michael Hutchinson

Michael Hutchinson

Senior Vice President, General Counsel
Andrew J. Shogan

Andrew J. Shogan

President, Multi-Disciplinary Oncology
Andy Whitman

Andy Whitman

Senior Vice President, Government Affairs, Policy & Market Development
Show more

Varian Medical Systems Office Locations

Varian Medical Systems has offices in Palo Alto, Atlanta, Charlottesville, Des Plaines and in 20 other locations
Palo Alto, CA, US (HQ)
Building 4, 3120 Hansen Way M
Atlanta, GA, US
3290 Northside Pkwy NW
Charlottesville, VA, US
Charlottesville, VA, USA
Des Plaines, IL, US
Des Plaines, IL, USA
Milpitas, CA, US
660 N McCarthy Blvd
Seattle, WA, US
Seattle, WA, USA
Show all (24)

Varian Medical Systems Financials and Metrics

Varian Medical Systems Revenue

Varian Medical Systems's revenue was reported to be $3.17 b in FY, 2020
USD

Revenue (Q1, 2021)

778.8m

Gross profit (Q1, 2021)

359.0m

Gross profit margin (Q1, 2021), %

46.1%

Net income (Q1, 2021)

96.8m

EBIT (Q1, 2021)

117.2m

Market capitalization (16-Apr-2021)

16.3b

Closing stock price (16-Apr-2021)

177.1

Cash (1-Jan-2021)

773.0m

EV

15.6b
Varian Medical Systems's current market capitalization is $16.3 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

3.0b3.1b3.2b2.7b2.9b3.2b3.2b

Revenue growth, %

4%2%4%(17%)9%

Cost of goods sold

1.7b1.8b1.9b1.5b1.6b1.9b

Gross profit

1.3b1.3b1.4b1.2b1.3b1.4b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

737.9m759.4m784.0m757.1m758.8m789.4m763.3m655.0m662.4m678.5m729.9m709.1m741.0m779.4m825.8m828.9m407.3m320.2m778.8m

Cost of goods sold

410.8m436.9m469.0m447.4m441.5m443.0m428.8m379.7m369.1m375.7m411.4m395.5m424.9m461.2m474.4m462.1m263.1m225.2m419.8m

Gross profit

327.0m322.5m315.0m309.7m317.2m346.4m334.5m275.3m293.3m302.8m318.5m313.6m316.1m318.2m351.4m366.8m144.2m95.0m359.0m

Gross profit Margin, %

44%42%40%41%42%44%44%42%44%45%44%44%43%41%43%44%35%30%46%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

849.3m845.5m843.5m716.2m504.8m531.4m

Accounts Receivable

731.9m770.9m891.8m823.5m1.0b1.1b

Prepaid Expenses

148.6m164.0m145.7m199.8m233.3m206.2m

Inventories

572.3m612.6m639.7m439.7m438.1m551.5m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

904.4m862.2m951.4m953.4m961.1m835.9m814.7m705.5m658.2m822.6m739.9m536.0m616.0m546.3m520.7m721.9m667.8m769.2m773.0m

Accounts Receivable

663.0m707.9m673.7m768.5m852.6m840.4m801.7m761.5m747.5m880.1m936.7m933.6m989.5m1.0b1.1b1.1b1.0b987.4m1.0b

Prepaid Expenses

164.2m177.8m187.1m174.7m177.3m187.8m143.3m206.9m173.8m206.2m226.4m249.8m223.5m207.7m248.5m224.3m274.7m

Inventories

630.9m651.8m640.1m613.1m653.3m682.5m661.6m453.7m460.2m431.4m433.8m469.2m469.6m597.4m600.4m571.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

403.7m412.0m402.7m250.3m150.3m292.2m269.4m

Depreciation and Amortization

62.5m68.5m79.8m76.9m52.1m53.8m60.6m

Inventories

(43.3m)(41.6m)(27.7m)(100.0k)(16.4m)(106.9m)39.8m

Accounts Payable

2.0m6.5m9.7m5.5m21.9m49.7m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

93.3m199.3m312.9m89.0m186.0m284.9m21.0m77.0m167.6m(112.2m)(39.0m)33.5m103.9m192.3m221.8m88.9m192.9m96.8m

Depreciation and Amortization

17.1m33.4m50.0m18.5m37.9m56.4m22.3m41.0m58.5m19.1m35.8m53.5m17.5m37.2m56.1m10.2m49.6m44.9m9.8m

Inventories

(62.1m)(93.0m)(77.3m)(4.0m)(39.7m)(72.1m)(28.2m)(20.3m)(23.6m)(11.7m)(10.9m)(48.5m)(32.4m)(41.9m)(78.4m)(44.9m)(53.7m)(47.7m)(52.5m)

Accounts Payable

(37.0m)(12.8m)281.0k(14.2m)(13.6m)(5.1m)(20.7m)(9.9m)(600.0k)(10.3m)900.0k27.8m13.5m23.7m29.9m(54.7m)(94.3m)
USDFY, 2014

Debt/Equity

0.3 x

Debt/Assets

0.1 x

Financial Leverage

2.1 x
Show all financial metrics

Varian Medical Systems Operating Metrics

Varian Medical Systems's Backlog was reported to be $2.9b in Q3, 2018.
FY, 2014Q1, 2015Q2, 2015Q3, 2015Q4, 2015FY, 2015Q1, 2016Q2, 2016Q3, 2016Q4, 2016FY, 2016Q1, 2017Jan, 2017Q2, 2017Q3, 2017Q4, 2017FY, 2017Q1, 2018Q2, 2018Q3, 2018

Backlog

$3.2 b$3.12 b$3.09 b$3.14 b$3.48 b$3.34 b$3.28 b$3.06 b$3.45 b$3.39 b$3.14 b$3.26 b$3.52 b$3.02 b$2.93 b$2.95 b

Order Volume

$3.53 b$725.8 m$781.4 m$888 m$1.22 b$1.22 b$672 m$758.4 m$727.3 m$1.1 b$3.4 b$721.7 m$675.7 m$830.3 m$1.04 b$3.14 b$666.1 m$666 m$767.1 m

Linear Accelerators

7.5 k7.83 k

Proton Therapy Rooms Offered

50
Show all operating metrics

Varian Medical Systems Acquisitions / Subsidiaries

Company NameDateDeal Size
Boston ScientificJuly 03, 2019$90 m
PerkinElmer's Medical Imaging BusinessDecember 22, 2016
Candela's radiotherapy businessSeptember 07, 2016
TrueBeam SystemsMay 23, 2016
Claymount TechnologiesJuly 30, 2015$55 m
MeVis Medical Solutions AGApril 21, 2015
TranspireJuly 31, 2014
Velocity Medical SolutionsApril 04, 2014
Applied Computational TechnologiesDecember 06, 2013
InfimedMarch 05, 2012
Show more

Varian Medical Systems Revenue Breakdown

Embed Graph

Varian Medical Systems revenue breakdown by business segment: 5.1% from Varian Particle Therapy and 94.9% from Oncology Systems

Varian Medical Systems revenue breakdown by geographic segment: 46.2% from North America and 53.8% from International

Varian Medical Systems Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Varian Medical Systems Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Varian Medical Systems Online and Social Media Presence

Embed Graph

Varian Medical Systems Company Culture

  • Overall Culture

    B-

    68/100

  • CEO Rating

    A-

    75/100

  • Compensation

    B+

    76/100

  • Diversity

    C+

    67/100

Learn more on Comparably

Varian Medical Systems News and Updates

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Varian Medical Systems, Inc. (VAR)

NEW YORK, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California, Case No. 4:20-cv-06266-YGR on behalf of shareholders of Varian Medical Systems, Inc. (“Var…

Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), GCI Liberty, Inc. (NASDAQ: GLIBA), Maxim Integrated Products (NASDAQ:MXIM), National General Holdings Corp. (NASDAQ: NGHC), Pfenex Inc. (NYSE: PFNX), Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), and Varian Medical Systems, Inc. (NYSE: VAR)

NEW YORK, Sept. 10, 2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like...

Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging

MELBOURNE, Australia and PALO ALTO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announced it has entered into a strategic collaboration agreement with Palo Alto-based Varian Medical Systems, to evaluate the use of advanced prost…

SHAREHOLDER ALERT: WeissLaw LLP Investigates Varian Medical Systems, Inc.

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Varian Medical Systems, Inc. ("VAR" or the "Company") (NYSE: VAR) in connection with the proposed acquisition of the Company by...

Thinking about buying stock in ADT Inc, Varian Medical Systems, Lipocine Inc, Riot Blockchain, or United Airlines?

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ADT, VAR, LPCN, RIOT, and UAL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

Varian Medical Systems Blogs

Varian Steps in to Assist UPMC with Patient Treatments After Cyberattack on Irish Health Service

Varian Steps in to Assist UPMC with Patient Treatments After Cyberattack on Irish Health Service sandra.debiasi Tue, 07/13/2021 - 12:11 July 14, 2021 Patient radiotherapy treatments commenced within 36 hours  In May…

Varian Oncology Summit - Korea

Varian Oncology Summit - Korea sandra.debiasi Tue, 06/29/2021 - 12:42 Dec 11, 21 Seoul Korea Schedule …

CNS 2021 Tumor Section Satellite Symposium

CNS 2021 Tumor Section Satellite Symposium sandra.debiasi Tue, 06/29/2021 - 12:34 Oct 16, 21 - Oct 20, 21 Austin, TX United States Learn more Schedule …

ÖGRO - 38th Congress

ÖGRO - 38th Congress sandra.debiasi Tue, 06/29/2021 - 12:28 Oct 07, 21 - Oct 09, 21 Vienna, Austria Learn more Schedule …

5th FARO Meeting (Federation of Asian Organizations for Radiation Oncology)

5th FARO Meeting (Federation of Asian Organizations for Radiation Oncology) sandra.debiasi Tue, 06/29/2021 - 12:27 Oct 01, 21 - Oct 03, 21 Virtual Learn more Schedule …

WAIS 2021 CME Conference (Western Angiographic & Interventional Society)

WAIS 2021 CME Conference (Western Angiographic & Interventional Society) sandra.debiasi Tue, 06/29/2021 - 12:23 Sep 02, 21 - Sep 07, 21 Monterey, CA United States Learn more …
Show more

Varian Medical Systems Frequently Asked Questions

  • When was Varian Medical Systems founded?

    Varian Medical Systems was founded in 1948.

  • Who are Varian Medical Systems key executives?

    Varian Medical Systems's key executives are Chris Toth, Kathy Conner and Livia Freudl.

  • How many employees does Varian Medical Systems have?

    Varian Medical Systems has 10,062 employees.

  • What is Varian Medical Systems revenue?

    Latest Varian Medical Systems annual revenue is $3.2 b.

  • What is Varian Medical Systems revenue per employee?

    Latest Varian Medical Systems revenue per employee is $314.9 k.

  • Who are Varian Medical Systems competitors?

    Competitors of Varian Medical Systems include Zimmer Biomet, Ion Beam Applications and Elekta.

  • Where is Varian Medical Systems headquarters?

    Varian Medical Systems headquarters is located at Building 4, 3120 Hansen Way M, Palo Alto.

  • Where are Varian Medical Systems offices?

    Varian Medical Systems has offices in Palo Alto, Atlanta, Charlottesville, Des Plaines and in 20 other locations.

  • How many offices does Varian Medical Systems have?

    Varian Medical Systems has 24 offices.